CL
NKGN

CSS LLC’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

CSS LLC’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-52,753
Closed -$525K – 936
2022
Q4 		$525K Sell
52,753
-106,349
-67% -$1.05M 0.03% 371
2022
Q3 		$1.55M Sell
159,102
-131,948
-45% -$1.29M 0.07% 264
2022
Q2 		$2.83M Buy
291,050
+523
+0.2% +$5.09K 0.12% 213
2022
Q1 		$2.82M Buy
290,527
+189,424
+187% +$1.84M 0.1% 202
2021
Q4 		$980K Buy
+101,103
New +$984K 0.03% 437

Other funds holding NKGN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

CSS LLC's NKGN Position: Q1 2023 in Review

CSS LLC sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2023, closing a stake of 52,753 shares — an estimated $525K sold.

CSS LLC first reported a position in NKGN in Q4 2021 and held it in 5 quarters. The position peaked at $2.83M in Q2 2022. 55 funds tracked by Wall St. Rank hold NKGN as of Q1 2023.

  • CSS LLC reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • CSS LLC sold 52,753 NKGen Biotech, Inc. Common Stock shares in Q1 2023, an estimated $525K.
  • CSS LLC first reported a position in NKGen Biotech, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • CSS LLC's NKGen Biotech, Inc. Common Stock position peaked at $2.83M in Q2 2022.
  • 55 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.